Thornton Law Firm
  • Home
  • About
  • Cases We Handle
    • Birth Defects
    • Drugs and Medical Devices Litigation
    • False Claims Act and Fraud
    • Mesothelioma and Asbestos
    • Personal Injury
    • PFAS Chemical Exposure
    • Silicosis
    • Toxic Torts
  • Attorneys
    • Our Partner Attorneys
      • Michael P. Thornton
      • David J. McMorris
      • David C. Strouss
      • Andrew S. Wainwright
      • Michael A. Lesser
      • Marilyn T. McGoldrick
      • Brad J. Mitchell
      • Andrea Marino Landry
      • Evan R. Hoffman
      • Leah McMorris
      • Brian J. Freer
      • Leslie-Anne Taylor
      • Christian F. Uehlein
    • Our Associate Attorneys
      • Ginger A. Gibbs
      • Malissa A. Riehl
      • Dhespina Poreci
      • Justin Carter
    • Of Counsel Attorneys
      • John T. Barrett
      • David Bricker
      • Patricia M. Flannery
    • Asbestos Staff
      • Allison Elder
      • Lisa Peterson
      • Joseph D. Souza
      • Chris Corradetti
      • David A. Talanian
  • Significant Cases
  • Blog
  • Careers
  • Contact
  • Call: (888) 491-9726
Select Page
FDA Announces Voluntary Recall of Defective EpiPens

FDA Announces Voluntary Recall of Defective EpiPens

by Marilyn McGoldrick, Esq. | Apr 27, 2017 | Uncategorized

Call 888-341-1405 for a free consultation with a recognized leader in personal injury and medical device litigation. You can also contact us online to discuss the details of your case. By: Marilyn McGoldrick, Esq. Published on April 27, 2017 On March 31, the U.S. Food...
FDA Announces Voluntary Recall of Defective EpiPens

FDA Backs Xarelto Despite Flawed Clinical Trial

by Marilyn McGoldrick, Esq. | Feb 1, 2017 | Uncategorized

Thornton Law Firm is no longer accepting new Xarelto cases. By: Marilyn McGoldrick, Esq. Published on February 1, 2017 Recently, issues were raised concerning the results of a clinical trial for the blood thinning drug Xarelto. It was discovered that a medical device...
FDA Announces Voluntary Recall of Defective EpiPens

Thalidomide, Frances Oldham Kelsey, And The Pharmaceutical Industry

by Michael A. Lesser | Sep 25, 2013 | Uncategorized

By Michael A. Lesser, Esq. Posted on Sep 25, 2013               Dr. Frances Oldham Kelsey Released in Germany in 1957 as an all-purpose sedative, but later widely used as a preventative treatment for “morning sickness,”...
FDA Announces Voluntary Recall of Defective EpiPens

DePuy ASR: First Bellwether Trial Postponed For Two Weeks

by Marilyn T. McGoldrick | Sep 9, 2013 | Uncategorized

By Marilyn T. McGoldrick, Esq. Posted on Sep 9, 2013 The first DePuy ASR bellwether trial over Johnson & Johnson DePuy Unit’s hip implants, scheduled to begin today, September 9th in the consolidated federal Multi-District Litigation, has been adjourned for...
FDA Announces Voluntary Recall of Defective EpiPens

Depuy Hip Recipients Prepare For More Trials In Hip Implant Litigation

by Marilyn T. McGoldrick | Sep 3, 2013 | Uncategorized

By Marilyn T. McGoldrick, Esq. Posted on Sep 3, 2013  The first bellwether trial in the federal court Multi-District Litigation over Johnson & Johnson’s DePuy Unit’s metal hip implants is scheduled to begin on Monday, September 9, 2013. The plaintiff...
Copyright © 2024 Thornton Law Firm. All rights reserved.

Tenlaw uses cookies to provide security and better understand how our website is used. By using this website, you agree with the use of cookies. For more information see our Cookie Notice. By clicking Accept, you agree to our privacy policy and use of these cookies.

Read Our Privacy Policy

Thornton Law Firm
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.